| 1 | Technology | XLK | +28.1% |
| 2 | Energy | XLE | +26.1% |
| 3 | Materials | XLB | +13.1% |
| 4 | Real Estate | XLRE | +12.3% |
| 5 | Industrials | XLI | +11.5% |
| 6 | Consumer Staples | XLP | +10.5% |
| 7 | Utilities | XLU | +3.1% |
| 8 | Healthcare | XLV | -1.1% |
| 9 | Consumer Disc. | XLY | -1.5% |
| 10 | Financials | XLF | -2.9% |
| 11 | Communication | XLC | -4.5% |
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q1 '26 | 5/4/26 | $-1.22 | $-1.28 | -4.9% | +19% | $0.0B | $0.0B | -71.2% | +69% |
| Q4 '25 | 2/12/26 | $-1.20 | $-1.37 | -14.2% | -211% | $0.0B | $0.0B | -78.0% | -98% |
| Q3 '25 | 11/10/25 | $-1.30 | $-1.17 | +10.0% | -16% | $0.0B | $0.0B | -89.0% | +48% |
| Q2 '25 | 8/4/25 | $-1.43 | $-1.29 | +9.8% | +13% | $0.0B | $0.0B | -86.3% | +73% |
| Q1 '25 | 5/6/25 | $-1.25 | $-1.58 | -26.4% | -10% | $0.0B | $0.0B | -86.5% | +72% |